189 related articles for article (PubMed ID: 10405750)
1. Autoimmune lymphoproliferative syndrome: a syndrome associated with inherited genetic defects that impair lymphocytic apoptosis--CT and US features.
Avila NA; Dwyer AJ; Dale JK; Lopatin UA; Sneller MC; Jaffe ES; Puck JM; Straus SE
Radiology; 1999 Jul; 212(1):257-63. PubMed ID: 10405750
[TBL] [Abstract][Full Text] [Related]
2. Pathological findings in human autoimmune lymphoproliferative syndrome.
Lim MS; Straus SE; Dale JK; Fleisher TA; Stetler-Stevenson M; Strober W; Sneller MC; Puck JM; Lenardo MJ; Elenitoba-Johnson KS; Lin AY; Raffeld M; Jaffe ES
Am J Pathol; 1998 Nov; 153(5):1541-50. PubMed ID: 9811346
[TBL] [Abstract][Full Text] [Related]
3. Expression in transgenic mice of dominant interfering Fas mutations: a model for human autoimmune lymphoproliferative syndrome.
Choi Y; Ramnath VR; Eaton AS; Chen A; Simon-Stoos KL; Kleiner DE; Erikson J; Puck JM
Clin Immunol; 1999 Oct; 93(1):34-45. PubMed ID: 10497009
[TBL] [Abstract][Full Text] [Related]
4. ALPS: an autoimmune human lymphoproliferative syndrome associated with abnormal lymphocyte apoptosis.
Puck JM; Sneller MC
Semin Immunol; 1997 Feb; 9(1):77-84. PubMed ID: 9106310
[TBL] [Abstract][Full Text] [Related]
5. Autoimmune lymphoproliferative syndrome (ALPS) caused by Fas (CD95) mutation mimicking sarcoidosis.
Müllauer L; Emhofer J; Wohlfart S; Pichlhöfer B; Stary S; Ebetsberger G; Mannhalter C; Chott A
Am J Surg Pathol; 2008 Feb; 32(2):329-34. PubMed ID: 18223337
[TBL] [Abstract][Full Text] [Related]
6. Autoimmune lymphoproliferative syndrome (ALPS) in a patient with a new germline Fas gene mutation.
Del-Rey MJ; Manzanares J; Bosque A; Aguiló JI; Gómez-Rial J; Roldan E; Serrano A; Anel A; Paz-Artal E; Allende LM
Immunobiology; 2007; 212(2):73-83. PubMed ID: 17336828
[TBL] [Abstract][Full Text] [Related]
7. Autoimmune lymphoproliferative syndrome: report of two cases and review of the literature.
Oren H; Ozkal S; Gülen H; Duman M; Uçar C; Atabay B; Yilmaz S; Kargi A; Irken G
Ann Hematol; 2002 Nov; 81(11):651-3. PubMed ID: 12454704
[TBL] [Abstract][Full Text] [Related]
8. Characteristic T helper 2 T cell cytokine abnormalities in autoimmune lymphoproliferative syndrome, a syndrome marked by defective apoptosis and humoral autoimmunity.
Fuss IJ; Strober W; Dale JK; Fritz S; Pearlstein GR; Puck JM; Lenardo MJ; Straus SE
J Immunol; 1997 Feb; 158(4):1912-8. PubMed ID: 9029133
[TBL] [Abstract][Full Text] [Related]
9. Histologic features of sinus histiocytosis with massive lymphadenopathy in patients with autoimmune lymphoproliferative syndrome.
Maric I; Pittaluga S; Dale JK; Niemela JE; Delsol G; Diment J; Rosai J; Raffeld M; Puck JM; Straus SE; Jaffe ES
Am J Surg Pathol; 2005 Jul; 29(7):903-11. PubMed ID: 15958855
[TBL] [Abstract][Full Text] [Related]
10. Investigation of suspected deficient Fas-mediated apoptosis in a father and son.
Hanlon MG; Gacis ML; Kakakios AM; Kilham H
Cytometry; 2001 Mar; 43(3):195-8. PubMed ID: 11170106
[TBL] [Abstract][Full Text] [Related]
11. Autoimmune lymphoproliferative syndromes: genetic defects of apoptosis pathways.
Rieux-Laucat F; Le Deist F; Fischer A
Cell Death Differ; 2003 Jan; 10(1):124-33. PubMed ID: 12655301
[TBL] [Abstract][Full Text] [Related]
12. Autoimmune lymphoproliferative syndrome.
Sneller MC; Dale JK; Straus SE
Curr Opin Rheumatol; 2003 Jul; 15(4):417-21. PubMed ID: 12819469
[TBL] [Abstract][Full Text] [Related]
13. HLA B44 is associated with decreased severity of autoimmune lymphoproliferative syndrome in patients with CD95 defects (ALPS type Ia).
Vacek MM; Schäffer AA; Davis J; Fischer RE; Dale JK; Adams S; Straus SE; Puck JM
Clin Immunol; 2006 Jan; 118(1):59-65. PubMed ID: 16257267
[TBL] [Abstract][Full Text] [Related]
14. Clincal, immunologic, and genetic features of an autoimmune lymphoproliferative syndrome associated with abnormal lymphocyte apoptosis.
Sneller MC; Wang J; Dale JK; Strober W; Middelton LA; Choi Y; Fleisher TA; Lim MS; Jaffe ES; Puck JM; Lenardo MJ; Straus SE
Blood; 1997 Feb; 89(4):1341-8. PubMed ID: 9028957
[TBL] [Abstract][Full Text] [Related]
15. Autoimmune lymphoproliferative syndrome: molecular basis of disease and clinical phenotype.
Worth A; Thrasher AJ; Gaspar HB
Br J Haematol; 2006 Apr; 133(2):124-40. PubMed ID: 16611303
[TBL] [Abstract][Full Text] [Related]
16. Autoimmune lymphoproliferative syndrome with somatic Fas mutations.
Holzelova E; Vonarbourg C; Stolzenberg MC; Arkwright PD; Selz F; Prieur AM; Blanche S; Bartunkova J; Vilmer E; Fischer A; Le Deist F; Rieux-Laucat F
N Engl J Med; 2004 Sep; 351(14):1409-18. PubMed ID: 15459302
[TBL] [Abstract][Full Text] [Related]
17. Identification of new Fas mutations in a patient with autoimmune lymphoproliferative syndrome (ALPS) and eosinophilia.
Aspinall AI; Pinto A; Auer IA; Bridges P; Luider J; Dimnik L; Patel KD; Jorgenson K; Woodman RC
Blood Cells Mol Dis; 1999; 25(3-4):227-38. PubMed ID: 10575548
[TBL] [Abstract][Full Text] [Related]
18. [Autoimmune lymphoproliferative syndrome: an inherited or a somatic defect of apoptosis].
Rieux-Laucat F
Med Sci (Paris); 2006; 22(6-7):645-50. PubMed ID: 16828042
[TBL] [Abstract][Full Text] [Related]
19. Reversible monoclonal lymphadenopathy in autoimmune lymphoproliferative syndrome with functional FAS (CD95/APO-1) deficiency.
Ströbel P; Nanan R; Gattenlöhner S; Müller-Deubert S; Müller-Hermelink HK; Kreth HW; Marx A
Am J Surg Pathol; 1999 Jul; 23(7):829-37. PubMed ID: 10403307
[TBL] [Abstract][Full Text] [Related]
20. The clinical spectrum in a large kindred with autoimmune lymphoproliferative syndrome caused by a Fas mutation that impairs lymphocyte apoptosis.
Infante AJ; Britton HA; DeNapoli T; Middelton LA; Lenardo MJ; Jackson CE; Wang J; Fleisher T; Straus SE; Puck JM
J Pediatr; 1998 Nov; 133(5):629-33. PubMed ID: 9821419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
